HING YIP Holdings (00132) terminates the acquisition of 51% equity interest in Hope Meditech (Guangzhou).

HING YIP HLDGS (00132) announced that its subsidiary, Guangdong Zhongchuangxingke Asset Management Co., Ltd., plans to acquire 51% of the equity of HuYanSuo Medical Technology (Guangzhou) for a total consideration of 54.4353 million yuan. According to the equity transfer agreement, as the conditions for the initial payment (including the agreed completion of asset divestiture and debt repayment) were not satisfied within 12 months from the date of the signing of the equity transfer agreement, all parties confirmed on April 1, 2026 that the equity transfer agreement has been terminated in accordance with its terms. To avoid doubt, the Board of Directors believes that the termination of the equity transfer agreement will not have any significant adverse impact on the Group's business operations and financial condition.